1. Field of the Invention
This invention relates to the field of orthopedic surgery and, in particular, the treatment of fractures by implantation of bone screws for compression and medication.
2. Description of the Prior Art
The use of bone screws for stabilization and fixation of fractures is conventional. The use of lag screws for compression of fractures is also conventional, as shown by McCarthy, U.S. Pat. No. 5,514,138.
Lag screws and anchors with additional holding devices are taught by Bramlet, U.S. Pat. No. 5,849,004 and U.S. Pat. No. 6,443,954. These devices have curved talons which deploy from the interior of a cannulated body to increase the holding power.
Bone pins or screws have been used to access the interior of bones for application of diagnostic and structural components. For example, Kyle, U.S. Pat. No. 4,760,844, teaches the use of a cannulated screw for applying X-ray opaque dye and U.S. Pat. No. 4,653,489 teaches the use of a cannulated lag screw to apply polymethylmethacrylate (PMMA) or bone cement to the interior of a broken bone. In both these devices, the exuded material exits near the distal end of the screw which places the material in the immediate area of the screw threads.
What is lacking in the prior art is a lag screw with devices to increase the holding power of the screw and medicate the afflicted area while maintaining the ability to remove the devices and the screw.
A device for the treatment of a femoral neck trauma which includes basilar, mid-cervical and sub-cap fractures. The device is a compression screw assembly having a side plate, a compression screw and a cortical screw, which are implantable. A syringe adaptor instrument delivers ortho-biologic material to the fracture site through the lag screw. The lag screw assembly utilizes a cannulated screw with external threads and deployable tangs to anchor into the femoral head and is implanted in such a manner as to have the lag screw threads and tangs located on the opposite side of the fracture from the side plate. The distal shaft of the lag screw interfaces with the side plate in a manner which allows axial translation only. To deliver ortho-biologic material to the fracture site, the syringe adaptor instrument is inserted into the cannulated lag screw prior to the installation of the compression screw and the material is forced through it and out exit holes located circumferentially around the lag screw between the fracture site and the deployable tangs.
Thus, an objective of this invention is to repair fractures with a compression screw assembly exerting compression across of the fragments of the bone.
Another objective is to inject a biological material through the compression screw assembly into the area of the fracture to aid in recovery.
A further objective of this invention is to provide the lag screw assembly with a separation between the screw threads and the injection ports.
Yet another objective of this invention is to provide the injection assembly with a seal between the injection ports and the screw threads.
Other objectives and advantages of this invention will become apparent from the following description taken in conjunction with the accompanying drawings wherein are set forth, by way of illustration and example, certain embodiments of this invention. The drawings constitute a part of this specification and include exemplary embodiments of the present invention and illustrate various objects and features thereof.
The implantable components 1, constructed of stainless steel or titanium alloy, or other medically acceptable materials shown in
The lag screw assembly 2, as shown in
The side plate 3, in
The syringe adaptor 6, in
To introduce the ortho-biologic material, plunger 30 of syringe 7 is depressed forcing the material through the internal bore 27 of syringe adaptor 6 and out the syringe adaptor fluid exit port 25 into the lag screw assembly tang clearance bore 18. For example, the ortho-biological material may be selected from such groups of substances as bone cements, such as PMMA and other adhesives, BMP, bone morphogenic proteins, DBM, demineralized bone matrix, BOTOX and other viral vectors, any bone marrow aspirate, platelet rich plasma, composite ceramic hydroxyapatite, tricalcium phosphate, glass resin mixtures, resorbable highly purified polylacttides/polylactides-co-glycolides and others. The treating agent may include hormonal, antibiotic, anti-cancer, or growth factor substances, among others.
With tang body 14 having a close fit in lag screw assembly tang clearance bore 18 and syringe adaptor external thread 26 engaged in tang body internal thread 15 and syringe adaptor shoulder 24 in contact with lag screw assembly shoulder 17, the fluid is forced to exit through lag screw assembly ortho-biologic material exit holes 12 and into the proximity of the fracture 8. After, the material is delivered, the syringe adaptor 6 is removed and compression screw 4 is engaged and the fracture 8 is compressed/reduced as previously described.
It will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, it is to be understood that the invention is not to be limited by the specific illustrated embodiment but only by the scope of the appended claims.
This application claims the benefit of the filing date of U.S. Provisional Application No. 60/444,735 filed Feb. 3, 2003 under 35 U.S.C. 119(e).
Number | Name | Date | Kind |
---|---|---|---|
3791380 | Dawidowski | Feb 1974 | A |
4653489 | Tronzo | Mar 1987 | A |
4760844 | Kyle | Aug 1988 | A |
5514138 | McCarthy | May 1996 | A |
5849004 | Bramlet | Dec 1998 | A |
6183474 | Bramlet et al. | Feb 2001 | B1 |
6443954 | Bramlet et al. | Sep 2002 | B1 |
Number | Date | Country | |
---|---|---|---|
20040193162 A1 | Sep 2004 | US |
Number | Date | Country | |
---|---|---|---|
60444735 | Feb 2003 | US |